Serum Institute & Biocon Biologics reach new equity investment structure

SILS will now make an additional equity investment of $150 million through the conversion of an earlier loan provided to Biocon Pharma into equity in BBL

from Companies https://ift.tt/d2Ms1SL
via IFTTT